The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | CIREL: irinotecan-loaded chemoembolisation in CRC liver metastases
Thomas Helmberger, MD, PhD, Muenchen Klinik Bogenhausen, München, Germany, discusses the interim analysis of the CIREL observational study, evaluating transarterial chemoembolisation (TACE) using irinotecan-eluting beads in patients with colorectal cancer (CRC) liver metastasis that are not eligible for curative treatment approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
